宇留野武人

ウルノタケヒト | Uruno Takehito

所属機関・部署：
職名：准教授

研究分野 (2件)：腫瘍生物学 , 機能生物化学

競争的資金等の研究課題 (1件)：

論文 (37件)：

Kazufumi Kunimura, Kazuhiko Yamamura, Takeshi Nakahara, Makiko Kido-Nakahara, Takehito Uruno, Yoshinori Fukui. Identification of a functional DOCK8 gene polymorphism associated with atopic dermatitis. Allergy. 2022. 77. 12. 3670-3672
Takaaki Tatsuguchi, Takehito Uruno, Yuki Sugiura, Kounosuke Oisaki, Daisuke Takaya, Daiji Sakata, Yoshihiro Izumi, Takaya Togo, Yuko Hattori, Kazufumi Kunimura, et al. Pharmacological intervention of cholesterol sulfate-mediated T cell exclusion promotes antitumor immunity. Biochemical and Biophysical Research Communications. 2022
Takaaki Tatsuguchi, Takehito Uruno, Yuki Sugiura, Daiji Sakata, Yoshihiro Izumi, Tetsuya Sakurai, Yuko Hattori, Eiji Oki, Naoto Kubota, Koshiro Nishimoto, et al. Cancer-derived cholesterol sulfate is a key mediator to prevent tumor infiltration by effector T cells. International Immunology. 2022
Matsubara K, Kunimura K, Yamane N, Aihara R, Sakurai T, Sakata D, Uruno T, Fukui Y. DOCK8 deficiency causes a skewing to type 2 immunity in the gut with expansion of group 2 innate lymphoid cells. Biochem Biophys Res Commun. 2021. 559. 135-140
Yasuhisa Kamikaseda, Takehito Uruno, Kazufumi Kunimura, Akihito Harada, Kuniko Saiki, Kounosuke Oisaki, Daiji Sakata, Takeshi Nakahara, Makiko Kido-Nakahara, Motomu Kanai, et al. Targeted inhibition of EPAS1-driven IL-31 production by a small-molecule compound. Journal of Allergy and Clinical Immunology. 2021

講演・口頭発表等 (1件)：

DOCK1 as a novel molecular target for controlling cancer cell survival and invasion
(25th Biennial Congress on the European Association for Cancer Research 2018)

学位 (1件)：

受賞 (1件)：

所属学会 (2件)：

日本生化学会 , 日本生理学会

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

宇留野 武人